A New Target for Anti-Inflammation Therapeutics
Researchers from Washington State University recently discovered a critical step in the body’s inflammatory response that may aid in the development of anti-inflammatory treatments. Their findings, which were published in the journal Nature Communications, cited an integrin beta 3 antibody developed by researchers at the Blood Center of Wisconsin and now available via the Kerafast